172 related articles for article (PubMed ID: 28839790)
1. Faecal calprotectin for differentiating between irritable bowel syndrome and inflammatory bowel disease: a useful screen in daily gastroenterology practice.
Banerjee A; Srinivas M; Eyre R; Ellis R; Waugh N; Bardhan KD; Basumani P
Frontline Gastroenterol; 2015 Jan; 6(1):20-26. PubMed ID: 28839790
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy].
García Sánchez Mdel V; González R; Iglesias Flores E; Gómez Camacho F; Casais Juanena L; Cerezo Ruiz A; Montero Pérez-Barquero M; Muntané J; de Dios Vega JF
Med Clin (Barc); 2006 Jun; 127(2):41-6. PubMed ID: 16801001
[TBL] [Abstract][Full Text] [Related]
3. Optimal cut-off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?
Jha AK; Chaudhary M; Dayal VM; Kumar A; Jha SK; Jha P; Purkayastha S; Ranjan R
JGH Open; 2018 Oct; 2(5):207-213. PubMed ID: 30483591
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology.
Dolwani S; Metzner M; Wassell JJ; Yong A; Hawthorne AB
Aliment Pharmacol Ther; 2004 Sep; 20(6):615-21. PubMed ID: 15352909
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.
Caviglia GP; Pantaleoni S; Touscoz GA; Adriani A; Rosso C; Smedile A; Pellicano R; Astegiano M; Bresso F
Scand J Gastroenterol; 2014 Dec; 49(12):1419-24. PubMed ID: 25369978
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility and outcome analysis of faecal calprotectin in Hawkes Bay District Health Board.
Bai W; Boswell T
N Z Med J; 2016 Apr; 129(1433):69-73. PubMed ID: 27349163
[TBL] [Abstract][Full Text] [Related]
7. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
Bonnín Tomàs A; Vila Vidal M; Rosell Camps A
Rev Esp Enferm Dig; 2007 Dec; 99(12):689-93. PubMed ID: 18290691
[TBL] [Abstract][Full Text] [Related]
8. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ
J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301
[TBL] [Abstract][Full Text] [Related]
9. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
[TBL] [Abstract][Full Text] [Related]
10. Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.
Melchior C; Aziz M; Aubry T; Gourcerol G; Quillard M; Zalar A; Coëffier M; Dechelotte P; Leroi AM; Ducrotté P
United European Gastroenterol J; 2017 Mar; 5(2):261-269. PubMed ID: 28344794
[TBL] [Abstract][Full Text] [Related]
11. Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
Khalil AF; Helmy EM; Massoud MN; Baddour NM; Metwally RH; Omar OM
Prz Gastroenterol; 2021; 16(3):219-223. PubMed ID: 34584583
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
14. Are we exposing patients with a mildly elevated faecal calprotectin to unnecessary investigations?
Seenan JP; Thomson F; Rankin K; Smith K; Gaya DR
Frontline Gastroenterol; 2015 Jul; 6(3):156-160. PubMed ID: 28839805
[TBL] [Abstract][Full Text] [Related]
15. Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care.
Conroy S; Hale MF; Cross SS; Swallow K; Sidhu RH; Sargur R; Lobo AJ
J Clin Pathol; 2018 Apr; 71(4):316-322. PubMed ID: 28844038
[TBL] [Abstract][Full Text] [Related]
16. Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
Dhaliwal A; Zeino Z; Tomkins C; Cheung M; Nwokolo C; Smith S; Harmston C; Arasaradnam RP
Frontline Gastroenterol; 2015 Jan; 6(1):14-19. PubMed ID: 25580205
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin: a 'real-world' view.
McFarlane M; Chambers S; Malik A; Lee B; Sung E; Nwokolo C; Waugh N; Arasaradnam R
BMJ Open; 2016 Jun; 6(6):e011041. PubMed ID: 27266773
[TBL] [Abstract][Full Text] [Related]
18. A simple method for assessing intestinal inflammation in Crohn's disease.
Tibble J; Teahon K; Thjodleifsson B; Roseth A; Sigthorsson G; Bridger S; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2000 Oct; 47(4):506-13. PubMed ID: 10986210
[TBL] [Abstract][Full Text] [Related]
19. Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review.
Asiri AS; Algarni SS; Althubaiti AQ; Alzubaidi MA; Alghamdi JA; Almalki GA
Cureus; 2023 Sep; 15(9):e45019. PubMed ID: 37829963
[TBL] [Abstract][Full Text] [Related]
20. Inpatient usage of faecal calprotectin in a tertiary hospital.
Barnes A; Spizzo P; Mountifield R
Intern Med J; 2022 Mar; 52(3):436-439. PubMed ID: 33009839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
